Trials / Completed
CompletedNCT03611400
The Effect of Probiotic Intake on Intestinal Permeability in Healthy Adults
The Effect of Probiotic Intake on Intestinal Permeability of Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
In this double blind, crossover study participants will take a placebo for 3 weeks each. Gut permeability will be assessed weekly using food-grade sugar molecules. On the second week, participants will take aspirin, which will make their intestine permeable to the sugars. Participants will be asked to provide urine and stool samples to assess gut permeability and microbial communities. No change in permeability to the small sugar probes is anticipated with the probiotic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | This probiotic is commercially available and contains L. helveticus R0052 (0.2 x 10\^9 CFU/capsule) and L. rhamnosus R0011 (3.8 x 10\^9 CFU/capsule) as active ingredients and ascorbic acid, hypromellose, magnesium stearate, saccharose, potato starch, titanium dioxide, and maltodextrin as excipients. |
| DIETARY_SUPPLEMENT | Placebo | The placebo contains ascorbic acid, hypromellose, magnesium stearate, saccharose, potato starch, titanium dioxide and maltodextrin. |
Timeline
- Start date
- 2018-08-22
- Primary completion
- 2019-04-15
- Completion
- 2019-04-15
- First posted
- 2018-08-02
- Last updated
- 2019-06-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03611400. Inclusion in this directory is not an endorsement.